HT
ASND icon

HAP Trading’s Ascendis Pharma A/S ASND Stock Holding History

HAP Trading’s Portfolio ASND Stock Details ASND Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q1 		– Sell
-12,299
Closed -$1.55M – 724
2023
Q4 		$1.55M Buy
+12,299
New +$1.23M 0.25% 90
2022
Q4 		– Sell
-18,199
Closed -$2.11M – 1507
2022
Q3 		$1.88M Buy
+18,199
New +$1.73M 0.13% 164

Other funds holding ASND

RCM
RA Capital Management Boston, Massachusetts $9.44B AUM 157.3% 1-Year Est. Return
Artisan Partners
Artisan Partners Milwaukee, Wisconsin $62.3B AUM 26.25% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Westfield Capital Management
Westfield Capital Management Boston, Massachusetts $23.8B AUM 49.45% 1-Year Est. Return
ACA
Avoro Capital Advisors New York $10.2B AUM 149.19% 1-Year Est. Return
Janus Henderson Group
Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
T. Rowe Price Investment Management
T. Rowe Price Investment Management Baltimore, Maryland $145B AUM 22.78% 1-Year Est. Return
Capital International Investors
Capital International Investors Los Angeles, California $427B AUM 29.17% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return

HAP Trading's ASND Position: Q1 2024 in Review

HAP Trading sold out of Ascendis Pharma A/S (ASND) in Q1 2024, closing a stake of 12,299 shares — an estimated $1.55M sold.

HAP Trading first reported a position in ASND in Q3 2022 and held it in 2 quarters. The position peaked at $1.88M in Q3 2022. 189 funds tracked by Wall St. Rank hold ASND as of Q1 2024.

  • HAP Trading reported no remaining Ascendis Pharma A/S position as of Q1 2024 after selling out during the quarter.
  • HAP Trading sold 12,299 Ascendis Pharma A/S shares in Q1 2024, an estimated $1.55M.
  • HAP Trading first reported a position in Ascendis Pharma A/S in Q3 2022 and held it in 2 quarters.
  • HAP Trading's Ascendis Pharma A/S position peaked at $1.88M in Q3 2022.
  • 189 funds tracked by Wall St. Rank held Ascendis Pharma A/S as of Q1 2024.

Based on HAP Trading's 13F filing for Q1 2024, filed 13 May 2024.